AIG
AKYA

American International Group’s Akoya BioSciences AKYA Stock Holding History

American International Group’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,425
Closed -$53.6K – 95
2024
Q1 		$53.6K Sell
11,425
-99
-0.9% -$514 ﹤0.01% 2765
2023
Q4 		$56.2K Buy
11,524
+389
+3% +$1.62K ﹤0.01% 2790
2023
Q3 		$51.8K Buy
11,135
+2,379
+27% +$13.7K ﹤0.01% 2807
2023
Q2 		$64.7K Buy
8,756
+1,145
+15% +$7.64K ﹤0.01% 2811
2023
Q1 		$62.3K Buy
7,611
+152
+2% +$1.59K ﹤0.01% 2652
2022
Q4 		$71.4K Sell
7,459
-28
-0.4% -$345 ﹤0.01% 2647
2022
Q3 		$88K Buy
7,487
+106
+1% +$1.4K ﹤0.01% 2612
2022
Q2 		$95K Buy
7,381
+718
+11% +$7.44K ﹤0.01% 2626
2022
Q1 		$73K Sell
6,663
-468
-7% -$5.43K ﹤0.01% 2709
2021
Q4 		$109K Buy
7,131
+2,896
+68% +$37.9K ﹤0.01% 2676
2021
Q3 		$59K Sell
4,235
-44
-1% -$736 ﹤0.01% 2962
2021
Q2 		$83 Buy
+4,279
New +$88.4K ﹤0.01% 2913

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

American International Group's AKYA Position: Q2 2024 in Review

American International Group sold out of Akoya BioSciences (AKYA) in Q2 2024, closing a stake of 11,425 shares — an estimated $53.6K sold.

American International Group first reported a position in AKYA in Q2 2021 and held it in 12 quarters. The position peaked at $109K in Q4 2021. 59 funds tracked by Wall St. Rank hold AKYA as of Q2 2024.

  • American International Group reported no remaining Akoya BioSciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 11,425 Akoya BioSciences shares in Q2 2024, an estimated $53.6K.
  • American International Group first reported a position in Akoya BioSciences in Q2 2021 and held it in 12 quarters.
  • American International Group's Akoya BioSciences position peaked at $109K in Q4 2021.
  • 59 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.